JP2009521512A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009521512A5 JP2009521512A5 JP2008547791A JP2008547791A JP2009521512A5 JP 2009521512 A5 JP2009521512 A5 JP 2009521512A5 JP 2008547791 A JP2008547791 A JP 2008547791A JP 2008547791 A JP2008547791 A JP 2008547791A JP 2009521512 A5 JP2009521512 A5 JP 2009521512A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- targeting peptide
- subject
- endometriosis
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000203 mixture Substances 0.000 claims 71
- 230000008685 targeting Effects 0.000 claims 33
- 108090000765 processed proteins & peptides Proteins 0.000 claims 32
- 201000009273 Endometriosis Diseases 0.000 claims 19
- 239000012636 effector Substances 0.000 claims 16
- 125000003275 alpha amino acid group Chemical group 0.000 claims 15
- 150000007523 nucleic acids Chemical class 0.000 claims 14
- 210000004027 cell Anatomy 0.000 claims 13
- 150000001413 amino acids Chemical class 0.000 claims 12
- XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 claims 8
- 108020004707 nucleic acids Proteins 0.000 claims 8
- 102000039446 nucleic acids Human genes 0.000 claims 8
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 claims 6
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 6
- 101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 claims 6
- 229940035638 gonadotropin-releasing hormone Drugs 0.000 claims 6
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 claims 4
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims 4
- 108090000790 Enzymes Proteins 0.000 claims 3
- 102000004190 Enzymes Human genes 0.000 claims 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 3
- 239000000194 fatty acid Substances 0.000 claims 3
- 229930195729 fatty acid Natural products 0.000 claims 3
- 150000004665 fatty acids Chemical class 0.000 claims 3
- 239000003550 marker Substances 0.000 claims 3
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims 3
- 150000003384 small molecules Chemical class 0.000 claims 3
- 238000006467 substitution reaction Methods 0.000 claims 3
- 239000003053 toxin Substances 0.000 claims 3
- 231100000765 toxin Toxicity 0.000 claims 3
- 108700012359 toxins Proteins 0.000 claims 3
- 229940122815 Aromatase inhibitor Drugs 0.000 claims 2
- 239000000556 agonist Substances 0.000 claims 2
- 230000003444 anaesthetic effect Effects 0.000 claims 2
- 239000003886 aromatase inhibitor Substances 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 239000002078 nanoshell Substances 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 239000000186 progesterone Substances 0.000 claims 2
- 229960003387 progesterone Drugs 0.000 claims 2
- 238000004393 prognosis Methods 0.000 claims 2
- -1 binding tag Substances 0.000 claims 1
- 210000004899 c-terminal region Anatomy 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000013022 formulation composition Substances 0.000 claims 1
- 108020001507 fusion proteins Proteins 0.000 claims 1
- 102000037865 fusion proteins Human genes 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75367705P | 2005-12-23 | 2005-12-23 | |
| PCT/US2006/062601 WO2007076501A2 (en) | 2005-12-23 | 2006-12-26 | Endometriosis cell targeting peptide and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009521512A JP2009521512A (ja) | 2009-06-04 |
| JP2009521512A5 true JP2009521512A5 (enExample) | 2010-02-04 |
Family
ID=38218861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008547791A Ceased JP2009521512A (ja) | 2005-12-23 | 2006-12-26 | 子宮内膜症細胞ターゲティングペプチドおよびその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US9006404B2 (enExample) |
| EP (1) | EP1966234A2 (enExample) |
| JP (1) | JP2009521512A (enExample) |
| CA (1) | CA2634934A1 (enExample) |
| WO (1) | WO2007076501A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7081446B2 (en) * | 2002-01-31 | 2006-07-25 | The Trustees Of Columbia University In The City Of New York | Long-acting follicle stimulating hormone analogues and uses thereof |
| US20080306034A1 (en) * | 2007-06-11 | 2008-12-11 | Juneau Biosciences, Llc | Method of Administering a Therapeutic |
| US20080305967A1 (en) * | 2007-06-11 | 2008-12-11 | Juneau Biosciences, Llc | Genetic Markers Associated with Endometriosis and Use Thereof |
| US8932993B1 (en) | 2007-06-11 | 2015-01-13 | Juneau Biosciences, LLC. | Method of testing for endometriosis and treatment therefor |
| US20120225824A1 (en) * | 2008-08-05 | 2012-09-06 | The Trustees Of Columbia University In The City Of New York | Mullerian inhibiting substance (mis) analogues |
| WO2010124101A2 (en) * | 2009-04-22 | 2010-10-28 | Juneau Biosciences, Llc | Genetic markers associated with endometriosis and use thereof |
| US9434991B2 (en) | 2013-03-07 | 2016-09-06 | Juneau Biosciences, LLC. | Method of testing for endometriosis and treatment therefor |
| US9783576B2 (en) | 2013-06-11 | 2017-10-10 | Sanford-Burnham Medical Research Institute | Compositions and methods for targeted endometriosis treatment |
| US11386065B2 (en) * | 2017-01-31 | 2022-07-12 | Salesforce.Com, Inc. | Database concurrency control through hash-bucket latching |
| JP6613499B2 (ja) | 2017-08-24 | 2019-12-04 | 学校法人藤田学園 | 細胞殺傷剤 |
| AU2020212604A1 (en) * | 2019-01-25 | 2021-07-22 | Fertility Lab Sciences, Llc | Uterine endometrial fluid for prediction of success in fertility treatment |
| GB202202919D0 (en) | 2022-03-02 | 2022-04-13 | Serac Healthcare Ltd | Methods for imaging integrin expression |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5660981A (en) * | 1994-06-06 | 1997-08-26 | E. I. Du Pont De Nemours And Company | Selection of diagnostic genetic markers in microorganisms and use of a specific marker for detection of salmonella |
| WO2000059547A2 (en) * | 1999-04-02 | 2000-10-12 | Center For Molecular Medicine And Immunology | Method of detecting endometriosis |
| WO2000067771A1 (en) * | 1999-05-06 | 2000-11-16 | The Burnham Institute | Antiangiogenic endostatin peptides, endostatin variants and methods of use |
| US20040031072A1 (en) * | 1999-05-06 | 2004-02-12 | La Rosa Thomas J. | Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement |
| AU2001277840A1 (en) * | 2000-03-07 | 2002-03-04 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
| AU5108201A (en) * | 2000-03-30 | 2001-10-15 | Amgen Inc | Cd20/ige-receptor like molecules and uses thereof |
| US20040001823A1 (en) * | 2000-04-19 | 2004-01-01 | Yeaman Grant R. | Methods of treating endometriosis |
| US6833447B1 (en) * | 2000-07-10 | 2004-12-21 | Monsanto Technology, Llc | Myxococcus xanthus genome sequences and uses thereof |
| US7214786B2 (en) * | 2000-12-14 | 2007-05-08 | Kovalic David K | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
| US7314974B2 (en) * | 2002-02-21 | 2008-01-01 | Monsanto Technology, Llc | Expression of microbial proteins in plants for production of plants with improved properties |
-
2006
- 2006-12-26 CA CA002634934A patent/CA2634934A1/en not_active Abandoned
- 2006-12-26 WO PCT/US2006/062601 patent/WO2007076501A2/en not_active Ceased
- 2006-12-26 US US11/616,098 patent/US9006404B2/en not_active Expired - Fee Related
- 2006-12-26 EP EP06846806A patent/EP1966234A2/en not_active Withdrawn
- 2006-12-26 JP JP2008547791A patent/JP2009521512A/ja not_active Ceased
-
2015
- 2015-04-10 US US14/683,520 patent/US10259844B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2642628T3 (es) | Suministro oral mejorado de péptidos, mediante la utilización de translocadores de membrana, segmentables mediante una enzima | |
| JP2009521512A5 (enExample) | ||
| CN101553243B (zh) | 组织损伤修复中的基质细胞衍生因子1的蛋白酶抗性突变体 | |
| CN104023784B (zh) | 供持续释放的活性剂制剂 | |
| ES2773766T3 (es) | Inhibidores de TFPI y métodos de uso | |
| US20120028880A1 (en) | Vegfr-1/nrp-1 targeting peptides | |
| JP2017513859A (ja) | 両末端peg化インテグリン結合性ペプチドおよびその使用方法 | |
| JP2008536483A5 (enExample) | ||
| RU2012106150A (ru) | Вариантные формы уратоксидазы и их применение | |
| JP2007508846A5 (enExample) | ||
| TW201629085A (zh) | 芋螺毒素(conotoxin)肽之修飾及用途 | |
| US20140073555A1 (en) | Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation | |
| US20140322332A1 (en) | Antagonists of muc1 | |
| US10206976B2 (en) | Protein particles comprising disulfide crosslinkers and uses related thereto | |
| McGonigle et al. | Neuropilin-1 drives tumor-specific uptake of chlorotoxin | |
| US20160207969A1 (en) | Clostridium difficile targeting moieties and constructs comprising said moieties | |
| CN110256574B (zh) | 融合多肽及在制备抗抑郁、神经退行性疾病药物中的应用 | |
| WO2018136779A2 (en) | OXALOBACTER FORMIGENES(Of)-DERIVED FACTORS FOR THE TREATMENT OF TREATMENT/PREVENTION OF EXCESS OXALATE LEVELS | |
| JP2012524079A5 (enExample) | ||
| CN115243699A (zh) | 分子导向系统肽及其用途 | |
| CN101906152B (zh) | STX2抑制性肽以及Vero毒素中和剂 | |
| CN107949372A (zh) | 烯醇酶1(Eno1)组合物及其用途 | |
| BRPI0906045B1 (pt) | Composição farmacêutica para administração nasal | |
| EP1602931A1 (en) | SR-A antagonists | |
| US12016899B2 (en) | Compositions comprising Sel1-derived peptides and methods of treatment/prevention of excess oxalate levels and associated conditions/diseases therewith |